BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21986317)

  • 1. Adult onset cardiac dilatation in a transgenic mouse line with Galβ1,3GalNAc α2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy.
    Suzuki O; Kanai T; Nishikawa T; Yamamoto Y; Noguchi A; Takimoto K; Koura M; Noguchi Y; Uchio-Yamada K; Tsuji S; Matsuda J
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(8):550-62. PubMed ID: 21986317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
    Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
    Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin induces dilated cardiomyopathy.
    Lee D; Oka T; Hunter B; Robinson A; Papp S; Nakamura K; Srisakuldee W; Nickel BE; Light PE; Dyck JR; Lopaschuk GD; Kardami E; Opas M; Michalak M
    PLoS One; 2013; 8(2):e56387. PubMed ID: 23437120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
    Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
    J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
    Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
    Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic analysis of acceptor specificity and reaction kinetics of five human α(2,3)sialyltransferases: Product inhibition studies illustrate reaction mechanism for ST3Gal-I.
    Gupta R; Matta KL; Neelamegham S
    Biochem Biophys Res Commun; 2016 Jan; 469(3):606-12. PubMed ID: 26692484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors.
    Sujino K; Jackson RJ; Chan NW; Tsuji S; Palcic MM
    Glycobiology; 2000 Mar; 10(3):313-20. PubMed ID: 10704530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells.
    Hatano K; Miyamoto Y; Nonomura N; Kaneda Y
    Int J Cancer; 2011 Oct; 129(8):1838-47. PubMed ID: 21165949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
    Dimitroff CJ; Pera P; Dall'Olio F; Matta KL; Chandrasekaran EV; Lau JT; Bernacki RJ
    Biochem Biophys Res Commun; 1999 Mar; 256(3):631-6. PubMed ID: 10080950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
    Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
    J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
    Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
    Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
    Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
    Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis for enzyme activity of mouse Galbeta1,3GalNAc alpha2,3-sialyltransferase (mST3Gal I).
    Kim KS; Oh SU; Lee JH; Lee YC
    Indian J Biochem Biophys; 2010 Jun; 47(3):135-40. PubMed ID: 20653283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the minimal catalytic domain of human Galbeta1-3GalNAc alpha2,3-sialyltransferase (hST3Gal I).
    Vallejo-Ruiz V; Haque R; Mir AM; Schwientek T; Mandel U; Cacan R; Delannoy P; Harduin-Lepers A
    Biochim Biophys Acta; 2001 Oct; 1549(2):161-73. PubMed ID: 11690653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of evolutionarily conserved glycosylation at Asn211 in the intracellular trafficking and activity of sialyltransferase ST3Gal-II.
    Ruggiero FM; Vilcaes AA; Iglesias-Bartolomé R; Daniotti JL
    Biochem J; 2015 Jul; 469(1):83-95. PubMed ID: 25916169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wisteria floribunda agglutinin staining for the quantitative assessment of cardiac fibrogenic activity in a mouse model of dilated cardiomyopathy.
    Nagai-Okatani C; Nishigori M; Sato T; Minamino N; Kaji H; Kuno A
    Lab Invest; 2019 Nov; 99(11):1749-1765. PubMed ID: 31253865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
    Hamamoto T; Kurosawa N; Lee YC; Tsuji S
    Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.